Literature DB >> 11319932

Sequencing and analysis of the Edwardsiella ictaluri plasmids.

D H Fernandez1, L Pittman-Cooley, R L Thune.   

Abstract

To determine possible functions of the Edwardsiella ictaluri plasmids, pEI1 and pEI2, we analyzed the sequence of both plasmids. Plasmid pEI1 is 4807 bp, with 51% G + C, and 23 possible open reading frames of 40 amino acids or greater. Plasmid pEI2 is 5643 bp, with 51% G + C, and 24 possible reading frames. Database searches indicated that pEI1 contains an insertion element and a ROM analog. In addition, pEI1 possesses an open reading frame with strong homology to SlrP, SspH1, and SspH2 of Salmonella typhimurium and IpaH of Shigella flexnari, which have leucine-rich repeat regions and are components of type III secretory systems. pEI2 has a frame with weak homology to Spa15 of S. flexnari 5 and InvB of S. sonnei and S. typhimurium, which are also type III secretory system components, three origins of replication, a Rep analog, and a multimer resolution site. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11319932     DOI: 10.1006/plas.2000.1499

Source DB:  PubMed          Journal:  Plasmid        ISSN: 0147-619X            Impact factor:   3.466


  12 in total

1.  Regulation of the Edwardsiella ictaluri type III secretion system by pH and phosphate concentration through EsrA, EsrB, and EsrC.

Authors:  Matthew L Rogge; Ronald L Thune
Journal:  Appl Environ Microbiol       Date:  2011-05-06       Impact factor: 4.792

2.  Anatomy of the replication origin of plasmid ColE2-P9.

Authors:  Masaru Yagura; Shin-Ya Nishio; Hideki Kurozumi; Cheng-Fu Wang; Tateo Itoh
Journal:  J Bacteriol       Date:  2006-02       Impact factor: 3.490

3.  Distinct functions of the two specificity determinants in replication initiation of plasmids ColE2-P9 and ColE3-CA38.

Authors:  Kazuteru Aoki; Miki Shinohara; Tateo Itoh
Journal:  J Bacteriol       Date:  2007-01-19       Impact factor: 3.490

4.  High-throughput bioluminescence-based mutant screening strategy for identification of bacterial virulence genes.

Authors:  Attila Karsi; Nagihan Gülsoy; Erin Corb; Pradeep R Dumpala; Mark L Lawrence
Journal:  Appl Environ Microbiol       Date:  2009-02-05       Impact factor: 4.792

5.  Edwardsiellosis caused by Edwardsiella ictaluri in laboratory populations of Zebrafish Danio rerio.

Authors:  John P Hawke; Michael Kent; Matt Rogge; Wes Baumgartner; Judy Wiles; Johnny Shelley; L Christine Savolainen; Robert Wagner; Katy Murray; Tracy S Peterson
Journal:  J Aquat Anim Health       Date:  2013-09       Impact factor: 1.625

6.  Signature-tagged mutagenesis of Edwardsiella ictaluri identifies virulence-related genes, including a salmonella pathogenicity island 2 class of type III secretion systems.

Authors:  Ronald L Thune; Denise H Fernandez; Jennifer L Benoit; Maria Kelly-Smith; Matthew L Rogge; Natha J Booth; Christie A Landry; Rachel A Bologna
Journal:  Appl Environ Microbiol       Date:  2007-10-26       Impact factor: 4.792

7.  A Salmonella enterica serovar typhimurium translocated leucine-rich repeat effector protein inhibits NF-kappa B-dependent gene expression.

Authors:  Andrea Haraga; Samuel I Miller
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

8.  Role of the Salmonella pathogenicity island 1 (SPI-1) protein InvB in type III secretion of SopE and SopE2, two Salmonella effector proteins encoded outside of SPI-1.

Authors:  Kristin Ehrbar; Andrea Friebel; Samuel I Miller; Wolf-Dietrich Hardt
Journal:  J Bacteriol       Date:  2003-12       Impact factor: 3.490

9.  The aspartate-semialdehyde dehydrogenase of Edwardsiella ictaluri and its use as balanced-lethal system in fish vaccinology.

Authors:  Javier Santander; Wei Xin; Zhao Yang; Roy Curtiss
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

10.  Identification and Characterization of Putative Translocated Effector Proteins of the Edwardsiella ictaluri Type III Secretion System.

Authors:  Lidiya P Dubytska; Matthew L Rogge; Ronald L Thune
Journal:  mSphere       Date:  2016-05-11       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.